Face blindness, a mystifying condition that can trick us into believing we recognize people we’ve never met or make us fail to recognize those we have, has been previously estimated to affect between 2 and 2.5 percent of people in the world. Now, a new study by researchers at Harvard Medical School (HMS) and the VA Boston Healthcare System is providing fresh insights into the disorder, suggesting it may be more common than currently believed.
The SLAS Discovery Editor's Top 10 annually showcases ten individual articles that stand out as the most innovative scientific achievements published in SLAS Discovery in the past 12 months.
The 2023 Shaffer Prize for Innovative Glaucoma Research recognizes two Shaffer Grant recipients whose projects best exemplify the pursuit of breakthrough ideas in the quest to better understand and cure glaucoma.
An international team of researchers led by Lithuanian scientists provide additional evidence that intracranial pressure plays an important role in normal-tension glaucoma, which accounts for up to 50 per cent of all glaucoma cases.
While early treatment of diabetes-related eye disease slowed progression to severe disease, it did not improve visual acuity compared with treating more severe disease once it developed, according to a clinical study from the DRCR Retina Network.
Researchers at Tel Aviv University identified a new genetic risk factor for the complex eye disease AMD (Age-related Macular Degeneration), a leading cause for loss of eyesight at an advanced age.
The American Macular Degeneration Foundation will be hosting multiple, awareness-spreading activities throughout February, which is AMD Awareness Month, including new films on living well with AMD.
Glaucoma is a common ocular disease in which the optic nerve malfunctions due to the increased intraocular pressure (IOP) caused by drainage canal blocking in the eye.
A new survey of Americans 40 and older reveals a concerning lack of knowledge about the leading cause of blindness and vision loss among older adults, age-related macular degeneration (AMD).
A fundamental problem of perception is to filter out relevant information from a highly variable environment.
Rockville, Md.—The Association for Research in Vision and Ophthalmology (ARVO) congratulates Tasneem Khatib DM, FRCOphth—recipient of the 2022 Point of View Award. Established by the Point of View Foundation (Fundació Punt de Vista), the award provides a $20,000 cash prize in recognition of an outstanding scholarly article related to efforts to restore vision through regenerative ophthalmology, biotechnology, whole eye transplantation or other approaches.
Rockville, Md.—The Association for Research in Vision and Ophthalmology (ARVO) Foundation announced today that the 2023 recipient of the Oberdorfer Award in Low Vision Research is Lisa Ostrin, OD, PhD, FARVO. In recognition of this achievement, she will receive a $1,250 honorarium, an inscribed award and invitations to special events at the ARVO Annual Meeting. She will also present a lecture during an invited speaker session at ARVO 2023.
The New Horizons Forum will take place on February 3rd at San Francisco’s iconic Westin St. Francis Hotel.
GRF's leadership awards will be presented at the Glaucoma 360 Annual Gala on February 2, 2023 at the iconic Westin St. Francis Hotel in San Francisco.
Santen will receive GRF’s highest honor, the Catalyst Award, at the Glaucoma 360 Annual Gala on February 2, 2023, in San Francisco.
The Association for Research in Vision and Ophthalmology (ARVO) announced today the 2023 recipients of the Dr. David L. Epstein Award:Since 2016, the Dr. David L. Epstein Award has been given annually to a well-established senior investigator with a documented history of conducting eye and vision research in glaucoma and of mentoring clinician-scientists to independent academic and research careers.
People with diabetes who experience periods of low blood sugar — a common occurrence in those new to blood sugar management — are more likely to have worsening diabetic eye disease. Now, researchers at Johns Hopkins Medicine say they have linked such low blood sugar levels with a molecular pathway that is turned on in oxygen-starved cells in the eye.
A total of 13 physicians at Mercy Medical Center representing multiple specialties have been named “Top Doctors” by Castle Connolly Medical Ltd. Castle Connolly identifies top doctors, both nationally and regionally, based on an extensive nominations process open to all licensed physicians in the United States.
Patients undergoing cataract surgery typically have their natural lens replaced with an artificial intraocular lens (IOL). But complications occasionally arise that require the placement of a more surgically challenging secondary IOL. Several techniques are available for secondary IOL placement, and each has its advantages and disadvantages.
The Association for Research in Vision and Ophthalmology (ARVO) Foundation announced today the recipients of the 2023 Pfizer Ophthalmics Carl Camras Translational Research Award:Granted annually to young investigators working in areas of translational research, each recipient will be awarded $12,000.
For a translator to turn one language (say, English) into another (say, Greek), she has to be able to understand both languages and what common meanings they point to, because English is not very similar to Greek.
Rockville, Md.—The Association for Research in Vision and Ophthalmology (ARVO) Foundation congratulates Miguel Flores-Bellver, PhD, recipient of the 2023 Bert M. Glaser, MD Award for Innovative Research in Retina. The award recognizes an early-career investigator who has made a novel discovery that impacted the understanding and/or treatment of a retinal disease or condition.
Rockville, Md.—The Association for Research in Vision and Ophthalmology (ARVO) Foundation congratulates Demetrios G. Vavvas, MD, PhD, the 2022 recipient of the Kreissig Award for Excellence in Retinal Surgery. Established by Ingrid Kreissig, MD, through the ARVO Foundation, the $30,000 award recognizes excellence in the understanding of the mechanisms of retinal disease requiring surgical management, innovative approaches to management, and/or outcomes of surgical treatment.
The FDA awarded the American Academy of Ophthalmology and Verana Health funding to support research into pediatric cataract surgery.
Researchers discover new clues for causes of adult-onset macular degeneration.
The Association for Research in Vision and Ophthalmology (ARVO) announced today the recipients of the 2023 ARVO Foundation Collaborative Research Fellowship: José Arthur Milhomens Filho, MD; Maria Constanza Paz, PhD; Raba Thapa, PhD.With the goal of strengthening ophthalmic research capacities worldwide, the Fellowship pairs early-career researchers from developing countries with collaborating scientists in well-established research laboratories.
The Association for Research in Vision and Ophthalmology (ARVO) Foundation congratulates Edmund Arthur, OD, PhD, the 2023 recipient of the Genentech Career Development Award for Underrepresented Minority (URM) Emerging Vision Scientists. Arthur will receive a two-year grant totaling $100,000 to support research and personnel costs for establishing an independent vision research program.
Patients considering LASIK vision correction surgery should weigh the risks as well as benefits and see a doctor who can assess whether they are a good candidate for the procedure, according to an ophthalmologist at UT Southwestern Medical Center.
Benjamin K. Mizell, MD, an anesthesiologist with a proven track record of leading major Mass Eye and Ear initiatives including its electronic medical record integration, has been named chief of Anesthesia at Mass Eye and Ear.
Vision impairment disproportionately impacts older adults
Scientists at the National Eye Institute (NEI) have developed a zebrafish model of NEDBEH—a rare genetic disorder that can cause coloboma, where parts of the eye are missing due to developmental defects. The model provides a new tool for understanding the eye's embryonic development. The NEI is part of the National Institutes of Health.
A smart intraocular lens that can be inserted into the eye to diagnose Alzheimer's has been developed for the first time in Korea.
The Glaucoma Foundation (TGF), partnering with the STEM Institute, is launching a unique pilot glaucoma education program in New York City that starts with the young. The program is the first of its kind.
The new UC San Diego Shiley EyeMobile for Children is driving to schools in San Diego County to serve low-income families in need of eye exams. The EyeMobile, a program of UC San Diego Health, will visit approximately 250 preschools to provide vision care to low-income students.
Two separate eye diseases may contribute to age-related macular degeneration (AMD), a leading cause of blindness in the United States, according to a new study from New York Eye and Ear Infirmary of Mount Sinai.
Stuart Therapeutics, Inc. announces that it has expanded its drug development pipeline, adding programs in diabetic macular edema and myopia.
Retinal cells grown from stem cells can reach out and connect with neighbors, according to a new study, completing a “handshake” that may show the cells are ready for trials in humans with degenerative eye disorders.Over a decade ago, researchers from the University of Wisconsin–Madison developed a way to grow organized clusters of cells, called organoids, that resemble the retina, the light-sensitive tissue at the back of the eye.
Bausch + Lomb, a leading global eye health company, and Glaucoma Research Foundation a non-profit organization with the vision of curing glaucoma, today announced the launch of ‘Screen, Protect, Cure,’ a campaign designed to provide educational resources and raise awareness of glaucoma.
Recent evidence has emerged to suggest that age-related macular degeneration (AMD) is a clinical risk factor for increased risk for infection and mortality.
Stuart Therapeutics, Inc., (hereinafter Stuart) announces that it has entered into a license agreement with AJU Pharm Co. Ltd. (hereinafter AJU), for Stuart's clinical stage drug candidate ST-100.
Dan Briceland, MD, this week begins his one-year term as the 127th president of the American Academy of Ophthalmology.
Recent evidence has emerged to suggest that age-related macular degeneration (AMD) is a clinical risk factor for increased risk for infection and mortality.
Studying mice, researchers at Washington University School of Medicine in St. Louis have found that proteins made by stem cells to help regenerate the cornea may become new targets for treating and preventing injuries to the cornea related to dry eye disease. When eyes are dry, the cornea is more susceptible to injury.
With early diagnosis and medical and/or surgical treatment, most people with glaucoma will not lose their sight.
The foundation is investing $1.1 million in studies that hold the potential to set new standards in the prevention and treatment of age-related macular degeneration
Anyone suffering dry skin, eczema, or insect bites will know the unpleasant effects of itchy skin.
Scientists used patient stem cells and 3D bioprinting to produce eye tissue that will advance understanding of the mechanisms of blinding diseases. The research team from the National Eye Institute (NEI), part of the National Institutes of Health, printed a combination of cells that form the outer blood-retina barrier—eye tissue that supports the retina's light-sensing photoreceptors. The technique provides a theoretically unlimited supply of patient-derived tissue to study degenerative retinal diseases such as age-related macular degeneration (AMD).
Research to Prevent Blindness announces a new round of awardees who are generating critical knowledge around a host of sight-threatening conditions. With this latest round of funding, RPB has provided more than $400 million in research funding.
RSS
Medicine keyboard_arrow_right
Sciencekeyboard_arrow_right
Life keyboard_arrow_right
Business keyboard_arrow_right
Journal News keyboard_arrow_right
By Location keyboard_arrow_right
Meetings, Grants, and Events keyboard_arrow_right
